Advertisement

Molecular Pathology of Cardiac Diseases Liable to Cause Sudden Death

  • F. Calabrese
  • C. Basso
  • G. Thiene
  • M. Valente
Conference paper

Abstract

A sudden death (SD) always has a tragic impact both on families and on the general community. Although cardiac diseases liable to result in SD are mostly well identified, the etiopathogenetic understanding of most of these disorders is poor. To improve presymptomatic diagnosis, prevention and treatment, we need to define these disorders at the molecular and cellular levels.

Keywords

Aortic Dissection Hypertrophic Cardiomyopathy Bicuspid Aortic Valve Marfan Syndrome Molecular Pathology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Watson JD, Crick FHC (1953) Molecular structure of nucleic acids: A structurefor deoxyribose nucleic acid. Nature 171:737–738PubMedCrossRefGoogle Scholar
  2. 2.
    Watson JD, Crick FHC (1953) Genetic implications of the structure ofdeoxyribonucleic acid. Nature 171:964–967PubMedCrossRefGoogle Scholar
  3. 3.
    WilkinsMHF, Stokes AR,WilsonHR(1953)Molecular structure of structure of deoxypentose nucleic acids. Nature171:748–750CrossRefGoogle Scholar
  4. 4.
    WatsonJD, Tooze J, Kurtz DT (1983) Recombinant DNA: a short course.Freeman, New YorkGoogle Scholar
  5. 5.
    RobertsR (1987) Integrated program for the training of cardiovascular fellows inmolecular biology. In: Albertini A, Lenfant C, Paoletti R (eds) Biotechnologyin clinical medicine. Raven Press, New York, pp 99–105Google Scholar
  6. 6.
    Haber E, Quertermous T, Matsueda GR et al (1989) Innovative approaches toplasminogen activator therapy. Science 243:51–56PubMedCrossRefGoogle Scholar
  7. 7.
    Saiki RK, Scharf S, Falona F et al (1985) Enzymatic amplification of β-globin genomic sequences andrestriction site analysis for diagnosis of sickle cell anemia. Science239:1350–1354CrossRefGoogle Scholar
  8. 8.
    ErlichHA, Gelfand D, Sninsky JJ (1991) Recent advances in the polymerase chainreaction. Science 252:1643–1651PubMedCrossRefGoogle Scholar
  9. 9.
    YournoJ (1992) A method for nested PCR with single closed reaction tubes. PCR Methods Appl2:60–65PubMedCrossRefGoogle Scholar
  10. 10.
    MartinAM, Webber S, Fricker J et al (1994) Acute myocarditis. Rapid diagnosis by PCR in children.Circulation 90:330–339Google Scholar
  11. 11.
    Chamberlain, JS, Gibbs RA, Ranier JE et al (1988) Deletion screening of the Duchenne musculardystrophy locus via multiplex DNA amplification. Nucleic Acids Res16:11141–11156PubMedCrossRefGoogle Scholar
  12. 12.
    Tanigawa G, Jarcho JA, Kass A et al (1990) A molecular basis for familial hypertrophic cardiomyopathy:an α/β cardiac myosin heavy chain hybrid gene. Cell 62:991–998PubMedCrossRefGoogle Scholar
  13. 13.
    Tautz D (1989) Hypervariability of simple sequences as a general source forpolymorphic DNAmarkers.Nucleic Acids Res 17:6463–6471PubMedCrossRefGoogle Scholar
  14. 14.
    Kagnoff MF, Harwood JI, Bugawan TL et al (1989) Structural analysis of the HLA-DR, DQ and DP alleleson the celiac disease associated HLA-DR3 (DRw17) haplotype. Proc Natl Acad Sci USA 86:6274–6278PubMedCrossRefGoogle Scholar
  15. 15.
    Scharf SJ, Friedmann A, Steinman L et al (1989) Specific HLA-DQB and HLA-DRB1 alleles confer sensitivity topemphigus vulgaris. Proc Natl Acad Sci USA 86:6215–6219PubMedCrossRefGoogle Scholar
  16. 16.
    Steiler H (1995) Mechanisms and genesof cellular suicide. Science 267:1445–1449CrossRefGoogle Scholar
  17. 17.
    TompsonCB (1995) Apoptosis in the pathogenesis and treatment of disease. Science267:1456–1462CrossRefGoogle Scholar
  18. 18.
    VauxDL,Strasser A(1996) The molecular biology of apoptosis. Proc Natl Acad Sci USA 93:2239–2244PubMedCrossRefGoogle Scholar
  19. 19.
    Olivetti G, Abbi R, Quaini F et al (1997) Apoptosis in the failing human heart. N Engl JMed336:1131–1141CrossRefGoogle Scholar
  20. 20.
    ItohG, Tamura J, Suzuki M et al (1995) DNA fragmentation of human infarctedmyocardial cells demonstrated by the nick end labeling method and DNA agarose gelelectrophoresis. Am J Pathol 146:1235–1331Google Scholar
  21. 21.
    Lane JR, Neuman DA, Lafond-Walker A et al (1993) Role of IL1 and tumor necrosis factor in Coxsackie virus-inducedautoimmune myocarditis. J Immunol 151:1682–1690PubMedGoogle Scholar
  22. 22.
    Gavrieli Y, Sherman Y, Ben-Sasson SA (1992)Identification of programmed cell death in situ via specific labeling ofnuclear DNA fragmentation. J Cell Biol119:493–501PubMedCrossRefGoogle Scholar
  23. 23.
    Ansari B, Coates BD, Greenstein BD, Hall PA (1993) In situ end labeling detects DNA strandbreaks in apoptosis and other physiological and pathological states.J Pathol170:1–8PubMedCrossRefGoogle Scholar
  24. 24.
    Schuler GD, Boguski MS, Stewart EA et al (1996) A gene map of the human genome. Science 274:540–546PubMedCrossRefGoogle Scholar
  25. 25.
    CaskeyCT (1987)Diseasediagnosisby recombinantDNA methods.Science236:1223–1228PubMedCrossRefGoogle Scholar
  26. 26.
    Fenoglio-PreiserC, Willman CL (1987)Molecular biology and the pathologist. Arch Pathol Lab Med 111:601–619PubMedGoogle Scholar
  27. 27.
    KillenA,Orr HT (1990) Molecular basis of human genetic disease: clinical applicationsof genetic linkage analysis. In: Fenoglio-Preisier CM, Willman CL, Kaufman N(eds) Molecular diagnostics in pathology. Williams & Wilkins, BaltimoreGoogle Scholar
  28. 28.
    Molkentin J, Firulli A, Black B et al (1996) MEF2B is a potent transactivator expressed in early myogeniclineages. MolCellBiol 16:3814–3824Google Scholar
  29. 29.
    MorriseyEE, Ip HS,LuMM etal(1996) GATA 6: a zinc finger transcription factor that is expressed in multiplecell lineages derived from lateral mesoderm. Dev Biol 177:309–322PubMedCrossRefGoogle Scholar
  30. 30.
    FishmanMC,ChienKR (1997) Fashioning the vertebrate heart: earliest embryonic decisions.Development 124:2099–3117PubMedGoogle Scholar
  31. 31.
    BaroldiG, Falzi G, Mariani F (1979) Sudden coronary death: a postmortem study in 208 selected cases compared to 97 control subjects. Am Heart J 98:20–31PubMedCrossRefGoogle Scholar
  32. 32.
    Davies MJ, Thomas A (1984) Thrombosis and acute coronary artery lesions insudden cardiac ischemic death. N Engl J Med 310:1137–1140PubMedCrossRefGoogle Scholar
  33. 33.
    Lambert EC, Menon VA, Wagner HR et al (1974) Sudden unexpected deathfrom cardiovascular disease in children. Am J Cardiol 34:89–96PubMedCrossRefGoogle Scholar
  34. 34.
    Driscoll DJ,EdwardsWD (1985) Sudden unexpected death in children and adolescents. J Am CollCardiol 5[Suppl B]:118B–121BCrossRefGoogle Scholar
  35. 35.
    Topaz O, Edwards JE(1985)Pathologic features of sudden death in children, adolescents, and young adults.Chest 87:476–482PubMedCrossRefGoogle Scholar
  36. 36.
    CorradoD, Basso C, Poletti A, Angelini A, Valente M, Thiene G (1994) Suddendeath in the young. Is coronary thrombosis the major precipitating factor?Circulation 90:2315–2323PubMedCrossRefGoogle Scholar
  37. 37.
    BassoC, Frescura C, Corrado D et al (1995) Congenital heart disease andsudden death in the young. Hum Pathol 26:1065–1072PubMedCrossRefGoogle Scholar
  38. 38.
    Corrado D, Basso C, Schiavon M, Thiene G (1998) Screening for hypertrophiccardiomyopathy in young athletes. N Engl J Med 339:364–369PubMedCrossRefGoogle Scholar
  39. 39.
    Spirito P, Seidman CE, McKenna WJ, Maron BJ (1997) The management ofhypertrophic cardiomyopathy. N Engl J Med 336:775–785PubMedCrossRefGoogle Scholar
  40. 40.
    Maron BJ, Roberts WC, McAllister HA, Rosing DR, EpsteinSE (1980) Sudden death in youngathletes. Circulation 62:218–229PubMedCrossRefGoogle Scholar
  41. 41.
    MaronBJ, Roberts WC (1979) Quantitative analysis of cardiac muscle celldisorganization in the ventricular septum of patients with hypertrophiccardiomyopathy. Circulation 59:689–706PubMedCrossRefGoogle Scholar
  42. 42.
    MaronBJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (smallvessel) coronary artery disease in hypertrophic cardiomyopathy. J Am CollCardiol 8:545–557CrossRefGoogle Scholar
  43. 43.
    BonneG, Carrier L, Richard Ps, Hainque B, Schwartz K (1998) Familial hypertrophiccardiomyopathy. From mutations to functional defects. Circulation Res83:580–593Google Scholar
  44. 44.
    Jarcho JA,McKennaW, Pare JAPet al(1989) Mapping a gene for familial hypertrophic cardiomyopathy to chromosome14q1. N Engl J Med 321:1372–1378PubMedCrossRefGoogle Scholar
  45. 45.
    PoetterK, Jiang H, Hassanzadeh S et al (1996) Mutation in either theessential or regulatory light chains of myosin are associated with a raremyopathy in human heart and skeletal muscle. Nat Genet 13:63–69PubMedCrossRefGoogle Scholar
  46. 46.
    WatkinsH, MacRae C, Thierfelder L et al (1993) A disease locus for familialhypertrophic cardiomyopathy maps to chromosome 1q3. Nat Genet 3:333–337PubMedCrossRefGoogle Scholar
  47. 47.
    KimuraA, Harada H, Park JEet al(1997) Mutations in the cardiac troponin I gene associated with hypertrophiccardiomyopathy. Nat Genet 16:379–382PubMedCrossRefGoogle Scholar
  48. 48.
    ThierfelderL, Watkins H, MacRae C et al (1994) Alpha-tropomyosin and cardiac troponin Tmutations cause familial hypertrophic cardiomyopathy: a disease of thesarcomere. Cell 77:701–712PubMedCrossRefGoogle Scholar
  49. 49.
    CarrierL, HengstenbergC, Beckmann JS et al (1993) Mappingof a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. NatGenet 4:311–313Google Scholar
  50. 50.
    MacRaeCA,GhaisasN, Kass S etal(1995) Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndromemaps to a locus on chromosome 7q3. J Clin Invest 96:1216–1220PubMedCrossRefGoogle Scholar
  51. 51.
    WatkinsH, RosenzweigA,Hwang DS etal(1992) Characteristics and prognostic implications of myosin smissense mutationsin familial hypertrophic cardiomyopathy. N Engl J Med 326:1108–1114PubMedCrossRefGoogle Scholar
  52. 52.
    EpsteinND, Cohn GM,CyranF, Fananapazir L (1992) Differences in clinical expression of hypertrophiccardiomyopathy associated with two distinct mutations in the beta-myosin heavychain gene. A 908Leu-Val mutation and a 403Arg-Gln mutation. Circulation86:345–352PubMedCrossRefGoogle Scholar
  53. 53.
    BonneG, Carrier L, Bercovici J et al (1995) Cardiac myosin bindingprotein-C gene splice acceptor site mutation is associated with familialhypertrophic cardiomyopathy. Nat Genet 11:438–440PubMedCrossRefGoogle Scholar
  54. 54.
    WatkinsH, Conner D, Thierfelder L et al (1995) Mutations in the cardiacmyosin binding protein-C gene on chromosome 11 cause familial hypertrophiccardiomyopathy. Nat Genet 11:434–437PubMedCrossRefGoogle Scholar
  55. 55.
    Watkins H, McKenna WJ, Thierfelder L et al (1995) Mutations in the genes for cardiac troponin T andtropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332:1058–1064PubMedCrossRefGoogle Scholar
  56. 56.
    ForissierJF, Carrier L, Farza H et al (1996) Codon 102 of the cardiac troponin T geneis a putative hot spot for mutations in familial hypertrophic cardiomyopathy.Circulation 94:3069–3073PubMedCrossRefGoogle Scholar
  57. 57.
    Thiene G, Nava A, Corrado D, Rossi L, Pennelli N (1988)Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med318:129–133PubMedCrossRefGoogle Scholar
  58. 58.
    NavaA, Rossi L, Thiene G (eds) (1997) Arrhythmogenic right ventricularcardiomyopathy/dysplasia. Elsevier, AmsterdamGoogle Scholar
  59. 59.
    Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M (1996)Arrhythmogenic rightventricular cardiomyopathy: dysplasia, dystrophy, or myocarditis? Circulation94:983–991PubMedCrossRefGoogle Scholar
  60. 60.
    McKennaWJ, Thiene G, Nava A et al (1994) Diagnosis of arrhythmogenic rightventricular dysplasia/cardiomyopathy. Br Heart J 71:215–218PubMedCrossRefGoogle Scholar
  61. 61.
    AngeliniA,Basso C, Nava A, Thiene G (1996) Endomyocardial biopsy in arrhythmogenic rightventricular cardiomyopathy. Am Heart J 132:203–206PubMedCrossRefGoogle Scholar
  62. 62.
    Richardson P, McKenna WJ, Bristow et al (1996) Report of the 1995 WHO/ISFC Task Force on thedefinition and classification of cardiomyopathies. Circulation 93:841–842PubMedCrossRefGoogle Scholar
  63. 63.
    NavaA, Thiene G, Canciani B et al (1988) Familial occurrence of right ventricular dysplasia. A study involing nine families. J AmColl Cardiol 12:1222–28CrossRefGoogle Scholar
  64. 64.
    Rampazzo A, Nava A, Danieli GA et al (1994) The gene for arrhythmogenic right ventricularcardiomyopathy maps to chromosome 14q23-q24. Hum Molec Genet 3:959–62PubMedCrossRefGoogle Scholar
  65. 65.
    Rampazzo A, Nava A, Erne P et al (1995) A new locus for arrhythmogenicright ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum Mol Genet11:2151–2154CrossRefGoogle Scholar
  66. 66.
    Severini GM, Krajinovic M,Pinamonti B et al (1996) A new locus for arrhythmogenic right ventriculardysplasia on the long arm of chromosome 14. Genomics 31:193–20PubMedCrossRefGoogle Scholar
  67. 67.
    Rampazzo A, Nava A, Miorin M et al (1997) ARVD4, a new locus for arrhythmogenic right ventricularcardiomyopathy, maps to chromosome 2 long arm. Genomics 45:259–263PubMedCrossRefGoogle Scholar
  68. 68.
    AhmadF, Duanxiang Li, Karibe A et al (1998) Localization of a generesponsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23.Circulation 98:2791–2795PubMedCrossRefGoogle Scholar
  69. 69.
    CoonarAS, Protonotarios N, Tsatsopoulou A et al (1998) Gene for arrhythmogenic rightventricular cardiomyopathy with diffuse nonepidermolytic palmoplantarkera-toderma and woolly hair (Naxos disease) maps to 17q21. Circulation97:2049–2058PubMedCrossRefGoogle Scholar
  70. 70.
    NavaA, Bauce B, VillanovaC et al (1999)Arrhythmogenic right ventricular cardiomyopathy: long term follow-up of 37families. J Am Coll Cardiol (Abst Suppl):49:7AGoogle Scholar
  71. 71.
    Mallat Z, Teddgui A, Fontaliran F, Frank R, Durigon M,Fontaine G (1996) Evidence of apoptosis in arrhythmogenic right ventriculardysplasia. N Engl J Med 335:1190–1196PubMedCrossRefGoogle Scholar
  72. 72.
    ValenteM, Calabrese F, Thiene G et al (1998) In vivo evidence of apoptosisin arrhythmogenic right ventricular cardiomyopathy. Am J Pathol 152:479–84PubMedGoogle Scholar
  73. 73.
    ThieneG, Corrado D, Nava A et al (1991) Right ventricular cardiomyopathy: is thereevidence of an inflammatory aetiology? Eur Heart J 12 [suppl D]:22–25PubMedCrossRefGoogle Scholar
  74. 74.
    ValenteM, Calabrese F, AngeliniA,Caforio ALP, Basso C, Thiene G (1997) Pathobiology. In: Nava A, Rossi L, ThieneG (eds) Arrhythmogenic right ventricular cardiomyopathy/dysplasia. ElsevierScience, AmsterdamGoogle Scholar
  75. 75.
    NeuspielDR, Kuller LH (1985)Sudden and unexpected natural death in childhood and adolescence. JAMA254:1321–1325PubMedCrossRefGoogle Scholar
  76. 76.
    PhillipsMP, Robinowtz M, Higgins JR et al (1986) Sudden cardiac death in AirForce recruits. JAMA 256:2696–2699PubMedCrossRefGoogle Scholar
  77. 77.
    Frustaci A, Bellocci F, Olsen EGJ (1994) Results of biventricular endomyocardial biopsy in survivorsof cardiac arrest with apparently normal hearts. Am J Cardiol 74:890PubMedCrossRefGoogle Scholar
  78. 78.
    Basso C, Boffa G, Corrado D, Thiene G (1997) Myocarditis and sudden death inthe young. Circulation 96:I–698Google Scholar
  79. 79.
    Wesslen L, Påhlson C, Lindquist O et al (1996) An increase in sudden unexpected cardiac deaths amongyoung Swedish orienteers during 1979-1992. Eur Heart J 17:902–910PubMedCrossRefGoogle Scholar
  80. 80.
    Akhtar N, Ni J, StrombergD et al (1999)Tracheal aspirate as a substrate for polymerase chain reaction detection ofviral genome in childhood pneumonia and myocarditis. Circulation 99:2011–2018PubMedCrossRefGoogle Scholar
  81. 81.
    Muntoni F, Cau M, Fanau A, Congiu R et al (1993) Deletion of the dystrophin muscle-promoter regionassociated with X-linked dilated cardiomyopathy. N Engl J Med 329:921–925PubMedCrossRefGoogle Scholar
  82. 82.
    Muntoni F, Wilson L, Marrosu G et al (1995) A mutation in the dystrophin gene selectively affectingdystrophin expression in the heart. J Clin Invest 96:693–699PubMedCrossRefGoogle Scholar
  83. 83.
    SchultzKR, GarjarskiRJ, Pignatelli R etal(1995) Genetic heterogeneity in familial dilated cardiomyopathy. Biochem Mol Med 56:87–93PubMedCrossRefGoogle Scholar
  84. 84.
    DurandJB,Bachinski LL, Bieling LC et al (1995) Localization of a generesponsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation92:3387–3389PubMedCrossRefGoogle Scholar
  85. 85.
    SiuBL (1997) A novel locus for familial dilated cardiomyopathy on chromosome 2p31.Proceedings of the second world congress of pediatric cardiology and cardiacsurgeryGoogle Scholar
  86. 86.
    KrajinovicM, Pinamonti B, Sinagra G et al (1995) Linkage of familial dilatedcardiomyopathy to chromosome 9. Am J Hum Genet 57:846–52PubMedGoogle Scholar
  87. 87.
    BowlesKR,GajarskiR, Porter P etal(1996) Gene mapping of familial autosomal dominant dilated cardiomyopathy tochromosome 10q21-23. J Clin Invest 98:1355–60PubMedCrossRefGoogle Scholar
  88. 88.
    KassS, MacRae C, GraberHL et al(1994) A gene defect that causes conduction system disease and dilatedcardiomyopathy maps to chromosome 1p1-1q1. Nat Genet 7:546–551PubMedCrossRefGoogle Scholar
  89. 89.
    OlsonTM, Keating MT (1996) Mapping a cardiomyopathy locus to chromosome 3p22-p25. JClin Invest 97:528–532CrossRefGoogle Scholar
  90. 90.
    Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT (1998) Actin mutations in dilatedcardiomyopathy: a heritable form of heart failure. Science 280:750–3PubMedCrossRefGoogle Scholar
  91. 91.
    MilasinJ, Muntoni F, Severini GM et al (1996) A point mutation in the 5’splice site of the dystrophin gene first intron responsible for X-linkedcardiomyopathy. Hum Mol Genet 5:73–79PubMedCrossRefGoogle Scholar
  92. 92.
    Ortiz Lopez R, Li H, Su J, Goytia V, Towbin JA (1997) Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy.Circulation 95:2434–40CrossRefGoogle Scholar
  93. 93.
    Bione S, D’Adamo P, Maestrini E, Gedeom AK, Bolhuis PA, Toniolo D (1996) A novel X-linked gene,G4.5, is responsible for Barth syndrome. Nat Genet 12:385–389PubMedCrossRefGoogle Scholar
  94. 94.
    Giacca M, Severini GM, Mestroni L et al (1994) Low frequency of detection by nested polymerase chainreaction of Enterovirus ribonucleic acid in endomyocardial tissue ofpatients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 24:1033–1040PubMedCrossRefGoogle Scholar
  95. 95.
    Andreoletti L, Hober D, Decoene C et al (1996) Detection of enteroviral RNA by polymerase chain reaction in endomyocardial tissue ofpatients with chronic cardiac diseases. J Med Virol 48:53–59PubMedCrossRefGoogle Scholar
  96. 96.
    Calabrese F, Valente M, Thiene G et al (1999) Enteroviral genome in native hearts may influence outcomeof patients who undergo cardiac transplantation. Diagn Mol Pathol (in press)Google Scholar
  97. 97.
    BrinkPA, Ferreira A, Moolman JC, Weymar HW, van der Merve PL,Corfield VA (1995) Gene for progressive familial heart block type I maps tochromosome 19q13. Circulation 91:1633–40PubMedCrossRefGoogle Scholar
  98. 98.
    DeMeeusA, StephanE,Debrus etal(1995) An isolated cardiac conduction disease maps to chromosome 19q. Circ Res77:735–740CrossRefGoogle Scholar
  99. 99.
    WolffL, Parkinson J, White PD (1930) Bundle branch block with short PR interval inhealthy young people prone to paroxysmal tachycardia. Am Heart J 5:685CrossRefGoogle Scholar
  100. 100.
    AndersonRH,BeckerAF, BrechenmacherC,Davies MJ, Rossi L (1975) Ventricular preexcitation. A proposed nomenclaturefor its substrates. Eur J Cardiol 3:27–36PubMedGoogle Scholar
  101. 101.
    Guize L, Soria R, Chaouat JC, Chretien JM, Houe D,le-Heuzey J (1985) Prevalence and course of Wolff-Parkinson-White syndromein a population of 138,048 subjects. Ann Med Intern Paris 136:474–478Google Scholar
  102. 102.
    Wellens HJJ, DurrerD(1974) Wolff-Parkinson-White syndrome and atrial fibrillation. Am J Cardiol34:777–782PubMedCrossRefGoogle Scholar
  103. 103.
    SchwartzLS,Goldfischer J,Sprague GJ, Schartz SP (1969) Syncope and sudden death in aortic stenosis.Am J Cardiol 23:647–658PubMedCrossRefGoogle Scholar
  104. 104.
    TurriM, Thiene G, Bortolotti U, Milano A, Mazzucco A, Gallucci V (1990) Surgicalpathology of aortic valve disease. A study based on 602 specimens. Eur JCardiothorac Surg 4:556–560CrossRefGoogle Scholar
  105. 105.
    AngeliniA,Basso C, Grassi G, Casarotto D, Thiene G (1994) Surgical pathology of valvedisease in the elderly. Aging Clin Exp Res 6:225–237Google Scholar
  106. 106.
    PomeranceA (1972) Pathogenesis of aortic stenosis and its relation to age. Br Heart J34:569–574CrossRefGoogle Scholar
  107. 107.
    Giusti S, Cocco P, Thiene G (1991) Valvolaaortica bicuspide: una cardiopatia congenita “minore”arischio di catastrofiche complicanze. G Ital Cardiol 21:189–201PubMedGoogle Scholar
  108. 108.
    GaleAN, McKusick VA,HutchinsGM,Gott VL(1977) Familial congenital bicuspid aortic valve: secondary calcific aorticstenosis and aortic aneurysm. Chest 72:668–670PubMedCrossRefGoogle Scholar
  109. 109.
    EwartA, Morris C, Ensing G et al (1993) A human vascular disease, supravalvular aortic stenosis maps to chromosome 7. Proc NatlAcad Sci USA 90:3226–3230CrossRefGoogle Scholar
  110. 110.
    Curran ME, Atkinson D, Ewart A, Morris C, Leppert M,Keating MT (1993) The elastin gene is disrupted by a translocation associated withsupravalvular aortic stenosis. Cell 73:159–168PubMedCrossRefGoogle Scholar
  111. 111.
    WilliamsJCP, Barratt Boyes BG, Lowe JB (1961) Supravalvular aortic stenosis.Circulation 24:1311–1318PubMedCrossRefGoogle Scholar
  112. 112.
    MorrowAG, WaldhausenJA, PetersRL, Bloodwell RD, BraunwaldE(1959) Supravalvular aortic stenosis. Clinical, hemodynamic and pathologicobservations. Circulation 20:1003–1010PubMedCrossRefGoogle Scholar
  113. 113.
    ThieneG, Ho SY (1986) Aortic root pathology and sudden death in youth: review ofanatomical varieties. Appl Pathol 4:237–245PubMedGoogle Scholar
  114. 114.
    Corrado D, Basso C, Nava A, Rossi L, Thiene G (1997)Sudden death in young people with apparently isolated mitral valve prolapse. GItal Cardiol 27:1097–1105Google Scholar
  115. 115.
    MartiniB, Basso C, Thiene G (1995) Sudden death in mitral valve prolapse with Holtermonitoring - documented ventricular fibrillation evidence of coexistingarrhythmogenic right ventricular cardiomyopathy. Int J Cardiol 49:274–278PubMedCrossRefGoogle Scholar
  116. 116.
    PyeritzRE, Wappel MA (1983) Mitral valve dysfunction in the Marfan syndrome. Am J Med74:797–807PubMedCrossRefGoogle Scholar
  117. 117.
    Jaffe AS, Geltman EM, Rodney GE, Uitto J (1981) Mitralvalve prolapse. A consistent manifestation of type IV Ehlers-Danlos syndrome. Thepathogenetic role of the abnormal production of type III collagen. Circulation64:121–125PubMedCrossRefGoogle Scholar
  118. 118.
    DaviesMJ (1996) Stability and instability: two faces of coronary atherosclerosis. ThePaul Dudley Withe Lecture 1995. Circulation 94:2013–2020PubMedCrossRefGoogle Scholar
  119. 119.
    LibbyP, Egan D, Skarlatos S (1997) Roles of infectious agents in atherosclerosis andrestenosis: an assesment of evidence and need for future research. Circulation96:4095–4103PubMedCrossRefGoogle Scholar
  120. 120.
    HendrixMG, Salimans MM, van Boven CP et al (1990) High prevalence of latentlypresent cytomegalovirus in arterial walls of patients suffering from grade IIIatherosclerosis. Am J Pathol 136:23–28PubMedGoogle Scholar
  121. 121.
    JacksonLA, Campbell LA, Schmidt RA et al (1997) Specificity of detectionof Chlamydia pneumoniae in cardiovascular atheroma: evaluation of theinnocent bystander hypothesis. Am J Pathol 150:1785–90PubMedGoogle Scholar
  122. 122.
    Ramsay G (1998) DNA chips: state-of-the-art. Nat Biotechnol 16:40–44PubMedCrossRefGoogle Scholar
  123. 123.
    QiaoJ-H, Tripathi J, Mishra NK et al (1997) Role of macrophagecolony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. AmJ Pathol 150:1687–99Google Scholar
  124. 124.
    de Villiers WJS, Smith JD, Miyata M et al (1998) Macrophage phenotype in mice deficient in bothmacrophage-colony-stimulating factor (op) and apolipoprotein E. ArteriosclerThromb Vasc Biol 18:631–640CrossRefGoogle Scholar
  125. 125.
    IsnerJM,Kearney M, Bortman S et al (1995) Apoptosis in human atherosclerosis andrestenosis. Circulation 91:2703–2711PubMedCrossRefGoogle Scholar
  126. 126.
    Consensusstatement of the Joint Steering Committees of the UCARE and of the IdiopathicVentricular Fibrillation Registry of the United States (1997) Survivors ofout-of-hospital cardiac arrest with apparently normal heart. Need fordefinition and standardized clinical evaluation. Circulation 95:265–272CrossRefGoogle Scholar
  127. 127.
    CorradoD, Basso C, AngeliniA,Thiene G (1995) Sudden arrhythmic death in young people with apparently normalheart. J Am Coll Cardiol [Suppl]:18-8A (abstract)Google Scholar
  128. 128.
    Schwartz PJ, Locati EH, NapolitanoC, Priori SG (1995) The long QT syndrome. In: Zipes DP, Jalife J (eds) Cardiacelectrophysiology: from cell to bedside, 2nd ed. Saunders, PhiladelphiaGoogle Scholar
  129. 129.
    Romano C, Gemme G, Pongiglione R(1963) Aritmie cardiache rare dell’età pediatrica. Clin Pediatr 45:658–683Google Scholar
  130. 130.
    JervellA, Lange-Nielsen F (1957) Congenital deaf-mutism, functional heart disease withprolongation of the QTc interval and sudden death. Am Heart J 54:59–68PubMedCrossRefGoogle Scholar
  131. 131.
    Wang Q, Shen J, Splawski I et al (1995) SCN5A mutations associated with an inherited cardiacarrhythmia, long QT syndrome. Cell 80:805–11PubMedCrossRefGoogle Scholar
  132. 132.
    CurranME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT (1995) A molecularbasis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell80:795–803PubMedCrossRefGoogle Scholar
  133. 133.
    WangQ, Curran ME, Splawski I et al (1996) Positional cloning of a novelpotassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet12:17–23PubMedCrossRefGoogle Scholar
  134. 134.
    SplawskiI, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT (1997)Mutations in the hminK gene cause long QT syndrome and suppress Iks function.Nature Genet 17:338–340CrossRefGoogle Scholar
  135. 135.
    Schott JJ, Peltier S, Foley P et al (1995) Mapping of a new gene for the LQT syndrome. Am J Hum Genet57:1114–1122PubMedGoogle Scholar
  136. 136.
    Neyroud N, Tesson F, Denjoy I et al (1997) A novel mutation in the potassium channel gene KVLQT causesthe Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 15:186–189PubMedCrossRefGoogle Scholar
  137. 137.
    Splawski I, Timothy KW, Vincent GM et al (1997) Molecular basis of the long QT syndrome associatedwith deafness. N Engl J Med 336:1562–1567PubMedCrossRefGoogle Scholar
  138. 138.
    Schulze-Bahr E, Wang Q, Wedekind H, Haverkamp W, Chen Q, Sun Y (1997) KCNE1 mutations causeJervell and Lange-Nielsen syndrome. Nature Genet 17:267–8PubMedCrossRefGoogle Scholar
  139. 139.
    PrioriS, Barhanin J, HauerRNW et al (1999) Geneticand molecular basis of cardiac arrhythmias. Impact on clinical management. EurHeart J 20:174–195Google Scholar
  140. 140.
    Brugada P, Brugada J (1992) Right bundle branch block, persistent ST segmentelevation and sudden cardiac death: a distinct clinical andelectrocardiographic syndrome. J Am Coll Cardiol 20:1391–1396PubMedCrossRefGoogle Scholar
  141. 141.
    MartiniB, Nava A, Thiene G et al (1989) Ventricular fibrillation without apparentheart disease: description of six cases. Am Heart J 118:1203–1209PubMedCrossRefGoogle Scholar
  142. 142.
    CorradoD, Nava A, Buja G etal(1996) Familial cardiomyopathy underlies syndrome of right bundle branch block,ST segment elevation and sudden death. J Am Coll Cardiol 27:443–448PubMedCrossRefGoogle Scholar
  143. 143.
    ChenQ, KirschGE,Zhang D etal(1998) Genetic basis and molecular mechanism for idiopathic ventricularfibrillation. Nature 392:293–296PubMedCrossRefGoogle Scholar
  144. 144.
    LarsonEW, Edwards WD (1984) Risk factors of aortic dissection: a necropsy study of161 cases. Am J Cardiol 53:849–855PubMedCrossRefGoogle Scholar
  145. 145.
    Kainulainen K, Pulkkinen K, Savolainen A et al (1990) Location on chromosome 15 of the gene defectcausing Marfan syndrome. N Engl J Med 323:935–939PubMedCrossRefGoogle Scholar
  146. 146.
    DietzHC, OuttingGR, Pyeritz RE etal(1991) Marfan syndrome caused by a recurrent de novo missensemutation in the fibrillin gene. Nature 352:337–339PubMedCrossRefGoogle Scholar
  147. 147.
    DisertoriM, Bertagnoli C, Thiene G et al (1992) Aneurisma dissecantedell’aorta a carattere familiare. G Ital Cardiol 21:849–853Google Scholar
  148. 148.
    Edwards WD, Leaf DS, Edwards JE (1978) Dissecting aortic aneurysm associated with congenitalbicuspid aortic valve. Circulation 57:1022–1025PubMedCrossRefGoogle Scholar
  149. 149.
    RobertsCS,RobertsWC (1991) Dissection of the aorta associated with congenital malformation ofaortic valve. J Am Coll Cardiol 17:712–716PubMedCrossRefGoogle Scholar
  150. 150.
    McKusick VA, Logue RB, BahnsonHT (1957) Association of aortic valvular disease and cystic medial necrosis ofthe ascending aorta. Report of four instances. Circulation 16:188–194Google Scholar
  151. 151.
    Pachulski RT, Weinberg AL, Chan KW (1991) Aortic aneurysm in patients withfunctionally normal or minimally stenotic bicuspid aortic valve. Am J Cardiol67:781PubMedCrossRefGoogle Scholar
  152. 152.
    Nistri S, Sorbo MD, Basso C, Scognamiglio R, Thiene G (1999) Aortic root sizein patients with normally functioning bicuspid aortic valve. Proceedings of theWorld Symposium on Heart Valve Diseases, London UKGoogle Scholar
  153. 153.
    Lindsay J (1988) Coarctation of the aorta, bicuspid aortic valve and abnormalascending aortic wall. Am J Cardiol 61:182–184PubMedCrossRefGoogle Scholar
  154. 154.
    KappeteinAP, Gittenberger-de Groot AC, Zwinderman AH, Rohmer J, Poelmann RE, Huysmans HA(1991) The neural crest as a possible pathogenetic factor in coarctation of theaorta and bicuspid aortic valve. J Thorac Cardiovasc Surg 102:830–836PubMedGoogle Scholar
  155. 155.
    Bondermann D, Gharehbahi-Schnell E, Wollenek G, Maurer G, Baumgartner H,Lang IM(1999)Mechanisms underlying aortic dilatation in congenital aortic valvemalformation. Circulation 99:2138–2143CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2000

Authors and Affiliations

  • F. Calabrese
    • 1
  • C. Basso
    • 1
  • G. Thiene
    • 1
  • M. Valente
    • 1
  1. 1.Istituto di Anatomia PatologicaUniversità di PadovaPaduaItaly

Personalised recommendations